Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG.

Ann Intern Med. 2004 Jan 20;140(2):85-93.

PMID:
14734330
2.

An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M.

Bone Marrow Transplant. 2001 Oct;28(7):637-42. Review.

3.

Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.

Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA.

Am J Kidney Dis. 2005 Aug;46(2):270-7. Review.

PMID:
16112045
4.
5.

Autologous stem cell transplantation for primary systemic amyloidosis.

Comenzo RL, Gertz MA.

Blood. 2002 Jun 15;99(12):4276-82. Review.

6.

[A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].

Adam Z, Matýková M, Krejcí M, Pour L, Kissová J, Slechtová M, Chlupová G, Stavarová Y, Simonides J, Penka M, Mayer J, Hájek R.

Vnitr Lek. 2010 Jan;56(1):67-78. Review. Czech.

PMID:
20184115
7.

[Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].

Thierry A, Bridoux F, Goodman H, Belmouaz S, Abou Ayache R, Desport E, Jaccard A, Touchard G.

Nephrologie. 2004;25(4):111-8. Review. French.

PMID:
15291138
8.

Managing systemic light-chain amyloidosis.

Comenzo RL.

J Natl Compr Canc Netw. 2007 Feb;5(2):179-87. Review.

PMID:
17335687
9.

New therapeutic approaches in primary systemic AL amyloidosis.

Sezer O, Eucker J, Schmid P, Possinger K.

Ann Hematol. 2000 Jan;79(1):1-6. Review.

PMID:
10663614
10.

[Treatment of amyloidosis].

Wien TN.

Tidsskr Nor Laegeforen. 2008 Jun 12;128(12):1397-400. Review. Norwegian.

11.

An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.

Sanchorawala V, Seldin DC.

Amyloid. 2007 Dec;14(4):261-9. Review.

PMID:
17968685
12.

Therapy for immunoglobulin light chain amyloidosis: the new and the old.

Gertz MA, Lacy MQ, Dispenzieri A.

Blood Rev. 2004 Mar;18(1):17-37. Review.

PMID:
14684147
13.

High dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis.

Sanchorawala V.

Hematol Oncol Clin North Am. 2014 Dec;28(6):1131-44. doi: 10.1016/j.hoc.2014.08.013. Epub 2014 Sep 30. Review.

PMID:
25459183
14.

Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review.

Mhaskar R, Kumar A, Behera M, Kharfan-Dabaja MA, Djulbegovic B.

Biol Blood Marrow Transplant. 2009 Aug;15(8):893-902. doi: 10.1016/j.bbmt.2009.01.022. Epub 2009 Apr 2. Review.

15.

Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.

Schönland SO, Dreger P, de Witte T, Hegenbart U.

Bone Marrow Transplant. 2012 Jul;47(7):895-905. doi: 10.1038/bmt.2011.152. Epub 2011 Jul 25. Review.

PMID:
21785469
16.

Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.

Gertz MA, Lacy MQ, Dispenzieri A.

Bone Marrow Transplant. 2000 Mar;25(5):465-70. Review.

17.

[Current treatment of AL amyloidosis].

Kovacsovics T.

Rev Med Suisse Romande. 2000 Oct;120(10):771-5. Review. French.

PMID:
11109905
18.

Light chain (AL) amyloidosis: update on diagnosis and management.

Rosenzweig M, Landau H.

J Hematol Oncol. 2011 Nov 18;4:47. doi: 10.1186/1756-8722-4-47. Review.

19.
20.

Spontaneous rupture of the spleen in AL amyloidosis.

Oran B, Wright DG, Seldin DC, McAneny D, Skinner M, Sanchorawala V.

Am J Hematol. 2003 Oct;74(2):131-5. Review.

Supplemental Content

Support Center